NIH-funded research R01 grant

Immune and NGF factors in Alzheimer’s for adults with Down syndrome

Official title: The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome

Funded at University of California-Irvine · NIH-11582785 · Data updated 2026-11-12

This grant studies why people with Down syndrome develop Alzheimer’s disease by looking at immune signals and nerve growth factor problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine
NIH-funded
Lab location1 site (Irvine, United States)
Project startAugust 15, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$259,200
NIH project number3R01AG087280-03S1
Project IDNIH-11582785 on NIH RePORTER

Who could benefit from this research

Could help

Adults with Down syndrome, particularly those approaching or experiencing early AD-related changes.

Less likely to help

Individuals without Down syndrome or without AD-related changes are less likely to benefit.

What this research studies

People with Down syndrome are at high risk for Alzheimer’s as they age, and this project will explore how immune dysregulation and NGF metabolism contribute to that process. Researchers will examine biomarkers and pathways outside the usual AT(N) framework to better understand when and how AD develops in DS. The goal is to identify new signs of disease and potential targets that could guide future preventive trials. The study builds on strong international collaborations to translate findings into real-world questions for patients and families.

Why it matters

Potential benefit: If successful, the work could lead to earlier detection and new approaches to prevent or delay Alzheimer’s symptoms in people with Down syndrome.

How similar studies have gone: Previous DS-AD research has revealed key pathology links; this project aims to extend those findings with new biomarkers and immune/NGF pathways.

Where this research is happening

  • University of California-Irvine
    Irvine, United States
    Active

Researchers

  • Principal investigator: Busciglio, Jorge a — University of California-Irvine
  • Study coordinator: Busciglio, Jorge a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.